LP185667-5
Prulifloxacin
Active
Description
Prulifloxacin is an oral, broad spectrum fluoroquinolone antimicrobial drug. It is metabolized to ulifloxacin, its active form, by first pass metabolism in the liver. It is effective against both gram positive and gram negative bacteria, and indications for use include urinary tract infection and exacerbation of chronic bronchitis. PMID: 18044063 Source: Regenstrief LOINC, PMID: 18044063
Basic Part Properties
- Part Display Name
- Prulifloxacin
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2014-07-27
- Construct for LOINC Short Name
- Prulifloxacin
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP185667-5
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 普卢沙星 Synonyms: 普卢利沙星; |
| es-ES | Spanish (Spain) | Prulifloxacina |
| it-IT | Italian (Italy) | Prulifloxacina |
| tr-TR | Turkish (Turkey) | Prulifloksasin |
| nl-NL | Dutch (Netherlands) | prulifloxacine |
| fr-CA | French (Canada) | Prulifloxacine |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright